TD Cowen Downgrades Apogee Therapeutics Inc (APGE) to Hold

June 23, 2026 4:37 PM

TD Cowen analyst Tyler Van Buren downgraded Apogee Therapeutics Inc (NASDAQ: APGE) from Buy to Hold.

For an analyst ratings summary and ratings history on Apogee Therapeutics Inc click here. For more ratings news on Apogee Therapeutics Inc click here.